Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Enanta Pharmaceuticals, Inc. (ENTA)

« Back to company index

ENTA Chatter Timeline

Stock Ticker for ENTA

Most Active Tweeters for ENTA

UserTweets
@Tickeron 10
@Gambiste1 3
@dakotafinancial 3
@DewDiligence 2
@dispatchtribune 2

Recent Tweets for ENTA

Gambiste1 @Gambiste1
RT @Tickeron: $ENTA's price moved above its 50-day Moving Average on November 25, 2019. View odds for this and other indicators: https://t.…
December 7th 2019, 8:12pm
Tickeron @Tickeron
$ENTA's price moved above its 50-day Moving Average on November 25, 2019. View odds for this and other indicators:… https://t.co/Hn8vcEPOrG
December 7th 2019, 8:12pm
dakotafinancial @dakotafinancial
Enanta Pharmaceuticals $ENTA Lifted to “Sell” at BidaskClub https://t.co/keL0CpOSKh
December 7th 2019, 2:12pm
Tickeron @Tickeron
$ENTA's price moved above its 50-day Moving Average on November 25, 2019. View odds for this and other indicators:… https://t.co/re7W7R0D0y
December 6th 2019, 9:12pm
dispatchtribune @dispatchtribune
Analysts Anticipate Enanta Pharmaceuticals Inc $ENTA Will Post Earnings of $0.63 Per Share https://t.co/cMw2MjbIMH
December 6th 2019, 6:12am
EnterpriseLeade @EnterpriseLeade
Zacks: Brokerages Expect Enanta Pharmaceuticals Inc $ENTA to Announce $0.63 Earnings Per Share https://t.co/xTz8hXRvGu
December 6th 2019, 6:12am
AmericanBanking @AmericanBanking
Zacks: Brokerages Expect Enanta Pharmaceuticals Inc $ENTA to Announce $0.63 Earnings Per Share https://t.co/jUqviSocdn #stocks
December 6th 2019, 6:12am
dailypoliticaln @dailypoliticaln
Enanta Pharmaceuticals $ENTA Upgraded at BidaskClub https://t.co/9ral56Warg
December 6th 2019, 6:12am
TickerReport @TickerReport
BidaskClub Upgrades Enanta Pharmaceuticals $ENTA to “Sell” https://t.co/eqgz2pFkEi
December 6th 2019, 6:12am
Tickeron @Tickeron
$ENTA's price moved above its 50-day Moving Average on November 25, 2019. View odds for this and other indicators:… https://t.co/QSiwQ6GuRw
December 5th 2019, 8:12pm
dakotafinancial @dakotafinancial
Enanta Pharmaceuticals Inc $ENTA Receives Consensus Recommendation of “Hold” from Brokerages https://t.co/acWdRZV2yj
December 3rd 2019, 10:12am
AmericanBanking @AmericanBanking
Enanta Pharmaceuticals Inc $ENTA Receives Consensus Recommendation of “Hold” from Brokerages https://t.co/n3FsNf2evB #stocks
December 3rd 2019, 10:12am
tradersreport @tradersreport
RT @Tickeron: $ENTA in +1.76% Uptrend, growing for three consecutive days on November 29, 2019. View odds for this and other indicators: ht…
December 2nd 2019, 7:12pm
Tickeron @Tickeron
$ENTA in +1.76% Uptrend, growing for three consecutive days on November 29, 2019. View odds for this and other indi… https://t.co/x222lADIsq
December 2nd 2019, 7:12pm
tradersreport @tradersreport
RT @Tickeron: $ENTA in +1.76% Uptrend, advancing for three consecutive days on November 29, 2019. View odds for this and other indicators:…
December 1st 2019, 11:12pm
Tickeron @Tickeron
$ENTA in +1.76% Uptrend, advancing for three consecutive days on November 29, 2019. View odds for this and other in… https://t.co/qVca6EWuzY
December 1st 2019, 11:12pm
Tickeron @Tickeron
$ENTA in +1.76% Uptrend, advancing for three consecutive days on November 29, 2019. View odds for this and other in… https://t.co/8AsAwes9h3
December 1st 2019, 12:12am
Tickeron @Tickeron
$ENTA's 10-day Moving Average crossed above its 50-day Moving Average on November 26, 2019. View odds for this and… https://t.co/bB8AR2WRs1
November 29th 2019, 7:11pm
Tickeron @Tickeron
$ENTA's 10-day Moving Average broke above its 50-day Moving Average on November 26, 2019. View odds for this and ot… https://t.co/Aj9NpTYKuW
November 28th 2019, 5:11pm
Tickeron @Tickeron
$ENTA's 10-day Moving Average crossed above its 50-day Moving Average on November 26, 2019. View odds for this and… https://t.co/OT9jUo2eMd
November 27th 2019, 7:11pm
Stock_News_Now @Stock_News_Now
$ENTA: New SEC Filing for ENTA: Form 10-K (No. 0001564590-19-044729): https://t.co/6EKtGPYIJs
November 27th 2019, 4:11pm
investor_feed @investor_feed
$ENTA 10-K Enanta Pharmaceuticals (27 Nov, 4:06pm) ? 2019 FY Earnings https://t.co/wfHQr5HAzP #ENTA #10K… https://t.co/yDqpyaGiIn
November 27th 2019, 4:11pm
Tickeron @Tickeron
$ENTA's price moved above its 50-day Moving Average on November 25, 2019. View odds for this and other indicators:… https://t.co/p4zEXQWmCp
November 27th 2019, 12:11am
SwingTradeBot @SwingTradeBot
Rose Above Upper Bollinger Band today: $ENTA ... https://t.co/AyIukUGmib
November 26th 2019, 2:11pm
BlueBioNow @BlueBioNow
$ENTA considerable price movement 3.07 % change recently https://t.co/Lw9D5c1Gqa
November 26th 2019, 5:11am
dakotafinancial @dakotafinancial
Enanta Pharmaceuticals $ENTA Downgraded by Zacks Investment Research https://t.co/wtkQScxOI4
November 26th 2019, 3:11am
TheMarketsDaily @TheMarketsDaily
Enanta Pharmaceuticals $ENTA Downgraded by Zacks Investment Research https://t.co/ItNViPDLSZ
November 26th 2019, 3:11am
ZolmaxNews @ZolmaxNews
JMP Securities Downgrades Enanta Pharmaceuticals $ENTA to Market Perform https://t.co/stmvo2yoII
November 26th 2019, 1:11am
DewDiligence @DewDiligence
RT @DewDiligence: @bio_clouseau $ENTA insiders are bullish too (new exercise-and-hold transaction reported today): https://t.co/68Vdmw6NCc
November 25th 2019, 5:11pm
DewDiligence @DewDiligence
@bio_clouseau $ENTA insiders are bullish too (new exercise-and-hold transaction reported today): https://t.co/68Vdmw6NCc
November 25th 2019, 5:11pm
InsiderAlertsIA @InsiderAlertsIA
$ENTA: New Insider Filing on Sr. VP & General Counsel NATHANIEL S. GARDINER: https://t.co/dOD5Of5BGz
November 25th 2019, 5:11pm
BlueBioNow @BlueBioNow
$ENTA substantial stock price changes -4.36 % change recently https://t.co/Lw9D5c1Gqa
November 25th 2019, 12:11pm
Gambiste1 @Gambiste1
RT @newsfilterio: Enanta Pharmaceuticals (NASDAQ:ENTA) Downgraded by Zacks Investment Research $ENTA https://t.co/NFuKXG61nd
November 25th 2019, 6:11am
stocknewstimes @stocknewstimes
Enanta Pharmaceuticals $ENTA Downgraded by Zacks Investment Research https://t.co/r6XuDkex9w
November 25th 2019, 5:11am
newsfilterio @newsfilterio
Enanta Pharmaceuticals (NASDAQ:ENTA) Downgraded by Zacks Investment Research $ENTA https://t.co/NFuKXG61nd
November 25th 2019, 5:11am
dispatchtribune @dispatchtribune
Zacks Investment Research Downgrades Enanta Pharmaceuticals $ENTA to Sell https://t.co/AyGhapo8fv
November 25th 2019, 5:11am
ThisLincolnian @ThisLincolnian
Enanta Pharmaceuticals $ENTA Lowered to Market Perform at JMP Securities https://t.co/EGrOurTziK
November 25th 2019, 4:11am
AdamB1438 @AdamB1438
Anybody follow $ENTA? This was a home run for me a couple of years ago, but haven't kept up for a couple of years.
November 24th 2019, 11:11am
WeekHerald @WeekHerald
Enanta Pharmaceuticals $ENTA Stock Rating Lowered by Zacks Investment Research https://t.co/kAfyKniEo3
November 24th 2019, 4:11am
OlympiaReport @OlympiaReport
Enanta Pharmaceuticals $ENTA Stock Rating Lowered by Zacks Investment Research https://t.co/QLIKX9DvVA
November 24th 2019, 4:11am
dailypoliticaln @dailypoliticaln
Enanta Pharmaceuticals $ENTA Rating Lowered to Market Perform at JMP Securities https://t.co/pWyMRLAlXs
November 24th 2019, 1:11am
TickerReport @TickerReport
Enanta Pharmaceuticals $ENTA Rating Lowered to Market Perform at JMP Securities https://t.co/rtgN0JdRnR
November 24th 2019, 1:11am
Gambiste1 @Gambiste1
RT @gcassidy718: $ENTA good earnings are hopefully coming next quarter -4.36 % change recently https://t.co/C3ytdcXv8r
November 24th 2019, 12:11am
gcassidy718 @gcassidy718
$ENTA good earnings are hopefully coming next quarter -4.36 % change recently https://t.co/C3ytdcXv8r
November 23rd 2019, 10:11pm
stocknewstimes @stocknewstimes
Enanta Pharmaceuticals $ENTA Downgraded by JMP Securities https://t.co/SNoqBD3ABx
November 23rd 2019, 2:11pm
TheMarketsDaily @TheMarketsDaily
Enanta Pharmaceuticals $ENTA Downgraded to Market Perform at JMP Securities https://t.co/IpxvGWaaNL
November 23rd 2019, 2:11pm
EnterpriseLeade @EnterpriseLeade
Enanta Pharmaceuticals $ENTA Cut to Sell at Zacks Investment Research https://t.co/QedzwtnNLr
November 23rd 2019, 12:11pm
TranscriptDaily @TranscriptDaily
Enanta Pharmaceuticals $ENTA Downgraded by Zacks Investment Research to Sell https://t.co/9cMz8OHycW
November 23rd 2019, 12:11pm
TheMarketsDaily @TheMarketsDaily
Enanta Pharmaceuticals $ENTA Releases Quarterly Earnings Results, Misses Expectations By $0.12 EPS https://t.co/ustLmsk6kM
November 23rd 2019, 8:11am
ZolmaxNews @ZolmaxNews
Enanta Pharmaceuticals $ENTA Downgraded by Zacks Investment Research https://t.co/FUgxorDnM5
November 22nd 2019, 10:11pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.